COGNITIVE ENHANCEMENT IN HEALTHY PEOPLE: PODCAST NOW AVAILABLE

July 27, 2012

COGNITIVE ENHANCEMENT IN HEALTHY PEOPLE: PODCAST NOW AVAILABLE

A recent international neuropharmacology conference included a session on the use of cognitive enhancers, such as methylphenidate (Ritilin) and modafinil (Modavigil).  The session featured a discussion between Professor David Nutt (director of the Neuropsychopharmacology unit at the Hammersmith Hospital, Imperial College London) and Nora Volkov (Director of the United States National Institute on Drug Abuse).  The two speakers have different opinions on the potential risks and benefits of cognitive enhancers, and a number of related ethical implications which arise out of the use of these drugs.  The audio from this fascinating discussion is available for download, or alternatively there's a transcript of the discussion available also.

Go to "Cognitive Enhancement in Healthy People"